A retrospective study to evaluate ceftazidime-avibactam for multidrug-resistant Gram-negative bacteria infections in Belgian tertiary hospital
Latest Information Update: 24 Jun 2020
At a glance
- Drugs Avibactam/ceftazidime (Primary)
- Indications Bacterial infections; Gram-negative infections
- Focus Therapeutic Use
- 24 Jun 2020 New trial record